Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W I White

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Virology|January 28, 1998
In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16W I White, S D Wilson, W Bonnez, et al.
Vaccine|August 1, 1995
Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigenW I White, D R Cassatt, J Madsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomasJ A Suzich, S J Ghim, F J Palmer-Hill, et al.
The Journal of Infectious Diseases|April 25, 2001
A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteersT G Evans, W Bonnez, R C Rose, et al.
Clinical Pharmacology and Therapeutics|March 21, 2013
Pharmacogenomics and translational simulations to bridge indications for an anti-interferon-α receptor antibodyB Wang, B W Higgs, L Chang, et al.
Journal of Virology|May 11, 1999
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1W I White, S D Wilson, F J Palmer-Hill, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Virology|January 28, 1998
In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16W I White, S D Wilson, W Bonnez, et al.
Vaccine|August 1, 1995
Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigenW I White, D R Cassatt, J Madsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomasJ A Suzich, S J Ghim, F J Palmer-Hill, et al.
The Journal of Infectious Diseases|April 25, 2001
A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteersT G Evans, W Bonnez, R C Rose, et al.
Clinical Pharmacology and Therapeutics|March 21, 2013
Pharmacogenomics and translational simulations to bridge indications for an anti-interferon-α receptor antibodyB Wang, B W Higgs, L Chang, et al.
Journal of Virology|May 11, 1999
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1W I White, S D Wilson, F J Palmer-Hill, et al.
Pageof 2